Person:
TANRIVERDİ, MÜBERRA

Profile Picture
Google ScholarScopusORCIDPublons
Status
Organizational Units
OrgUnit Logo
Organizational Unit
Job Title
First Name
MÜBERRA
Last Name
TANRIVERDİ
Name
Email Address
Birth Date

Filters

20241
Reset filters

Settings

Author: Kutlutürk Yikilmaz S. × Item Type: Publication × Has files: false × Subject: CLINICAL MEDICINE ×

Search Results

Now showing 1 - 1 of 1
  • No Thumbnail Available
    PublicationMetadata only
    Reliability and Validity of the Turkish Translation of the PedsQL™ 3.0 Neuromuscular Module for 2-to 4-Year-Olds in Spinal Muscular Atrophy.
    (2024-04-08) Kutlutürk Yikilmaz S.; TANRIVERDİ M.; OKTEM S.; TANRIVERDİ, MÜBERRA
    Background: The Pediatric Quality of Life InventoryTM Neuromuscular Module (PedsQLTM 3.0 NM) evaluates the health-related quality of life in children who are affected by neuromuscular diseases. This study’s aim is to assess the adaptation of the PedsQLTM 3.0 NM Turkish version (PedsQLTM 3.0 NM-TR) for 2-4 years old in spinal muscular atrophy (SMA). Methods: The procedure of translating the PedsQLTM 3.0 NM into Turkish was conducted in accordance with the translation methodology outlined by the PedsQLTM measurement model. The PedsQLTM 3.0 NM-TR was administered to 54 parents of children with SMA aged 2-4 years. The test-retest reliability and intraclass correlation coefficient (ICC) were measured for reliability analysis. Cronbach\"s alpha coefficient and item score correlations were calculated for internal consistency. Concurrent construct validity was evaluated by Pearson correlations between the outcomes of the PedsQLTM 4.0 Generic Core Scale (PedsQLTM 4.0 GCS) and the PedsQLTM 3.0 NM. Results: The PedsQLTM 3.0 NM-TR total score shows excellent reliability. The Cronbach\"s alpha values for the PedsQLTM 3.0 NM ranged between 0.871-0.906, while those for the PedsQLTM 4.0 GCS ranged 0.843-0.897. Test-retest ICC values for the PedsQLTM 3.0 NM-TR ranged 0.812-0.917, and for the PedsQLTM 4.0 GCS ranged 0.773-0.899. The relationship between the PedsQLTM 3.0 NM-TR and the subscores of the PedsQLTM 4.0 GCS demonstrated a range of correlations from excellent to fair, indicating the interplay between two scales. Conclusions: This study established the PedsQLTM 3.0 NM-TR as reliable, valid, and feasible for use in children aged 2-4 years old with SMA.